Pharmaceutical Strategies Group - PSG

Tired of lagging pharmacy program insights? PSG's new solutions, Artemetrx Rebate Monitor and Artemetrx Pricing Monitor, empower health plans with near real-time performance data to accelerate PBM transparency and optimize decision-making. Discover how these tools transform PBM oversight and drive significant value for health plans! Learn more here >> https://lnkd.in/gRb4NVD8

??? ?? Join fellow attendees Wednesday April 30th for a special event at Asembia's AXS25 Summit, the Women's Health Luncheon. Register for the conference here, www.asembiasummit.com. Looking forward to an insightful discussion. Thank you to Deloitte, CVS Health, Timely by DrFirst, Pharmaceutical Strategies Group - PSG for your support. See you at AXS25! #asembia25 #womenshealth #registernow

We're hiring! In the role of Director, PBM Contract Audit, you'll lead a talented team while leveraging your pharmacy benefit expertise to drive audit solutions that deliver measurable results for healthcare payers. Interested or know someone who might be? Check out the link below! See job details >> https://lnkd.in/gysreAK4

We recognize that our work would not be possible without the support of our dedicated industry partners. Each year, we honor those individuals who have gone above and beyond in our partnerships, providing outstanding service and support. Join us in acknowledging and thanking these 2024 All-Stars!

With healthcare payers increasingly exploring alternative pharmacy benefit strategies, many are considering the Modular PBA model to carve out or unbundle their PBA services. In our latest blog by Mandy Savino, we examine how to implement this approach by looking at various strategic considerations and walking through a high-level checklist of activities. Read now to evaluate whether this model could help your organization! Read blog >> https://lnkd.in/g_ZjPmY4

As healthcare costs soar with GLP-1 medications forecasted to reach $100 billion by 2030, payers face unprecedented challenges balancing member access with financial sustainability. Our experts developed "The Payer's 2025 Guide to GLP-1 Drugs," offering crucial insights into various clinical and financial considerations. Download our essential guide today and visit our GLP-1 Resources Hub to equip your organization with the tools needed to navigate this rapidly evolving landscape. Download guide >> https://lnkd.in/gUUfvYnj

It is almost that time of the year! AMCP Annual is coming up, and we're excited to be in attendance to learn from and connect with industry colleagues and partners. Want to have a discussion with our team? Reach out to Gary Golebiewski, Beth Hebert-Silvia, Jared Tate, Travis B., Angela Luong, or Tara Higgins to set something up!

RISE National is here! Don't miss tomorrow's session: "The Changing Landscape of The Pharmacy Under IRA, From a Health Plan Perspective" with Helen Liu, PharmD - Friday, March 14th at 10:50am. Discover how the IRA is transforming pharmacy operations now and in the future, plus practical strategies to enhance your benefits planning. Full session details >> https://lnkd.in/gUT4fjSa

Don't miss PSG thought leaders speaking at the 40th Annual Seminar by the Sea on Friday! Beth Hebert-Silvia will be a part of an expert panel in her session "Voices of Pharmacy Leadership Addressing Pressing Concerns and Priorities" | Friday, March 14th at 11am Tara Higgins will be diving into a GLP-1 discussion in her session "Exploring Diabetes and Weight Management with GLP-1s and More" | Friday, March 14th at 2:30pm Full session details >> https://lnkd.in/gNfPidAV

Payers continue to face significant challenges managing drug spend, with specialty drug trends rising in double digits and 74% of novel drugs approved by the FDA in 2024 being specialty medications. Renee Malarbi Rayburg breaks down the key pipeline developments shaping benefit strategies in our latest blog. Learn how you can prepare your organization for these important drug trends! Read blog >> https://lnkd.in/gu9u_ty7